S0502 Follow-Up Tumor Assessment Form NCT00324987 S0502 Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor Source Form: NCI FormBuilder:

  1. 9/19/12 9/19/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 6/9/15 6/9/15 -
Uploaded on:

June 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

S0502 Follow-Up Tumor Assessment Form NCT00324987

No Instruction available.

  1. StudyEvent: S0502 Follow-Up Tumor Assessment Form
    1. No Instruction available.
Target Lesions
Assessment Type (*)
Attenuation code
Non-target Disease
Assessment Type (*)
Non-target Disease
Assessment Type (*)
Recurrence code
New Lesions (specify Site)
Assessment Type (*)
Attenuation code
Symptomatic deterioration
Symptomatic deterioration

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial